Wuxi Biologics (Cayman) (WXIBF) Income Statement
Wuxi Biologics (Cayman) Income Statement
Last quarter (Q2 2026), Wuxi Biologics (Cayman)'s total revenue was $11.79B, an increase of 37.47% from the same quarter last year. In Q2, Wuxi Biologics (Cayman)'s net income was $2.44B. See Wuxi Biologics (Cayman)’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 21.79B | $ 18.68B | $ 17.03B | $ 15.27B | $ 10.29B | |
| $ 10.02B | $ 7.65B | $ 6.83B | $ 6.72B | $ 4.83B | |
| $ 3.38B | $ 2.68B | $ 2.38B | $ 2.38B | $ 1.64B | |
| Depreciation and Amortization | $ 1.72B | $ 1.44B | $ 1.17B | $ 800.67M | $ 481.78M |
| $ 8.37B | $ 6.43B | $ 5.50B | $ 6.22B | $ 4.51B | |
| $ 6.64B | $ 4.97B | $ 4.45B | $ 4.34B | $ 3.19B | |
| $ 617.16M | $ -139.41M | $ -276.39M | $ 1.02B | $ 805.01M | |
| $ 7.26B | $ 4.83B | $ 4.17B | $ 5.36B | $ 3.99B | |
| $ 4.91B | $ 3.36B | $ 3.40B | $ 4.42B | $ 3.39B | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.16 | $ 0.82 | $ 0.82 | $ 1.06 | $ 0.81 |
| Diluted EPS | $ 1.16 | $ 0.78 | $ 0.77 | $ 1.01 | $ 0.77 |
| Weighted Average Shares Outstanding | 4.18B | 4.08B | 4.16B | 4.17B | 4.40B |
| Weighted Average Shares Outstanding (Diluted) | 4.18B | 4.23B | 4.35B | 4.38B | 4.42B |
Currency in CNY